點擊這裡
Previous slide
Next slide
Previous slide
Next slide
Latest News
2022-11-04 Diamond Biotechnology Co., Ltd. And Taizong Biotechnology Co., Ltd, had joint agreement on Ronkyla. The revenue at first three quarters has reached a record high for both companies, due to the new product benefits and peak season effectives.
2022-11-04 [Financial Express] Diamond Biotechnology gain NT$30 million purchasing contract within Airlee Group on Southern East market next year.
2022-12-06  Announcement that The Diamond Biotechnology Co., Ltd.’s “Miracle Polydioxanone Absorbable Thread” has passed the domestic inspection and registration review of the TFDA of the Ministry of Health and Welfare and obtained a license.

     晶鑽生醫股份有限公司
     DIAMOND BIOTECHNOLOGY CO. INC
     股票代號 6815
     電話 +886-2-2755-3320
     傳真 +886-2-2755-3326
     台北市大安區復興南路二段45號11樓

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

     版權所有©2021
     晶鑽生醫股份有限公司保留所有權利

晶鑽生醫股份有限公司 DIAMOND BIOTECHNOLOGY CO. INC
Stock Code: 6815 | Tel: +886-2-2755-3320  |  Fax: +886-2-2755-3326
11F., No. 45, Sec. 2, Fuxing S. Rd., Da’an Dist., Taipei City 106, Taiwan (R.O.C.) Copyright © 2020 Diamond Biotechnology Co., Ltd. All rights reserved
Scroll to Top